Pharmamarketeer
wet- en regelgeving

Aethlon Medical gets US FDA nod to initiate early feasibility study of Hemopurifier in patients with head & neck cancer in combo Keytruda

10 oktober 2019
Pharma Biz

Aethlon Medical, a therapeutic medical device and technology company focused on unmet needs in global health, announced that the US FDA has approved its Investigational Device Exemption (IDE) application to initiate an Early Feasibility Study (EFS) of the company’s proprietary

Ook interessant voor je

Medhc-fases-banner
Advertentie(s)